Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	zinc ion sequestering activity	S100A7 S100A7A S100A7L2	2.34e-08	4	37	3	GO:0140486
GeneOntologyMolecularFunction	metal ion sequestering activity	S100A7 S100A7A S100A7L2	3.26e-07	8	37	3	GO:0140487
GeneOntologyMolecularFunction	RAGE receptor binding	S100A7 S100A7A S100A7L2	2.62e-06	15	37	3	GO:0050786
GeneOntologyMolecularFunction	cAMP-dependent protein kinase activity	PRKACA PRKACB	6.97e-05	7	37	2	GO:0004691
GeneOntologyMolecularFunction	structural constituent of presynaptic active zone	BSN ERC1	9.29e-05	8	37	2	GO:0098882
GeneOntologyMolecularFunction	cyclic nucleotide-dependent protein kinase activity	PRKACA PRKACB	1.19e-04	9	37	2	GO:0004690
GeneOntologyMolecularFunction	chemoattractant activity	S100A7 S100A7A S100A7L2	1.36e-04	54	37	3	GO:0042056
GeneOntologyMolecularFunction	AMP-activated protein kinase activity	PRKACA PRKACB	1.49e-04	10	37	2	GO:0004679
GeneOntologyMolecularFunction	molecular sequestering activity	S100A7 S100A7A S100A7L2	1.77e-04	59	37	3	GO:0140313
GeneOntologyMolecularFunction	calcium-dependent protein binding	S100A7 S100A7A S100A7L2	7.89e-04	98	37	3	GO:0048306
GeneOntologyMolecularFunction	G-protein beta/gamma-subunit complex binding	GNAI1 GNAT2	9.76e-04	25	37	2	GO:0031683
GeneOntologyMolecularFunction	structural constituent of synapse	BSN ERC1	2.75e-03	42	37	2	GO:0098918
GeneOntologyCellularComponent	centrosome	LRRCC1 GNAI1 CNTLN CCDC141 RBBP6 ERC1 PCNT PRKACA PRKACB	5.86e-06	770	37	9	GO:0005813
GeneOntologyCellularComponent	microtubule organizing center	LRRCC1 GNAI1 CNTLN CCDC141 RBBP6 ERC1 PCNT PRKACA PRKACB	2.41e-05	919	37	9	GO:0005815
GeneOntologyCellularComponent	cytoskeleton of presynaptic active zone	BSN ERC1	8.48e-05	8	37	2	GO:0048788
GeneOntologyCellularComponent	cAMP-dependent protein kinase complex	PRKACA PRKACB	1.36e-04	10	37	2	GO:0005952
GeneOntologyCellularComponent	presynaptic cytoskeleton	BSN ERC1	2.74e-04	14	37	2	GO:0099569
GeneOntologyCellularComponent	cell cortex	GNAI1 BSN ERC1 SPTBN1 SPINK5	4.68e-04	371	37	5	GO:0005938
GeneOntologyCellularComponent	presynaptic active zone cytoplasmic component	BSN ERC1	7.53e-04	23	37	2	GO:0098831
GeneOntologyCellularComponent	cilium	GNAT2 DNAH8 ERC1 PIP4K2A PCNT PRKACA PRKACB	8.78e-04	898	37	7	GO:0005929
GeneOntologyCellularComponent	cortical cytoskeleton	BSN ERC1 SPTBN1	1.53e-03	129	37	3	GO:0030863
GeneOntologyCellularComponent	heterotrimeric G-protein complex	GNAI1 GNAT2	1.75e-03	35	37	2	GO:0005834
GeneOntologyCellularComponent	GTPase complex	GNAI1 GNAT2	2.39e-03	41	37	2	GO:1905360
GeneOntologyCellularComponent	serine/threonine protein kinase complex	ERC1 PRKACA PRKACB	2.68e-03	157	37	3	GO:1902554
GeneOntologyCellularComponent	cell cortex region	BSN ERC1	2.88e-03	45	37	2	GO:0099738
GeneOntologyCellularComponent	protein kinase complex	ERC1 PRKACA PRKACB	3.35e-03	170	37	3	GO:1902911
GeneOntologyCellularComponent	centriole	LRRCC1 CNTLN PCNT	3.46e-03	172	37	3	GO:0005814
GeneOntologyCellularComponent	cytoplasmic region	BSN DNAH8 ERC1 PRKACA	3.65e-03	360	37	4	GO:0099568
GeneOntologyCellularComponent	extrinsic component of cytoplasmic side of plasma membrane	GNAI1 GNAT2	4.42e-03	56	37	2	GO:0031234
GeneOntologyCellularComponent	ciliary base	PRKACA PRKACB	4.42e-03	56	37	2	GO:0097546
Domain	S100A7	S100A7 S100A7A	3.82e-06	2	37	2	IPR028477
Domain	S100_CABP	S100A7 S100A7A S100A7L2	2.03e-05	27	37	3	PS00303
Domain	Gprotein_alpha_I	GNAI1 GNAT2	1.06e-04	8	37	2	IPR001408
Domain	G-alpha	GNAI1 GNAT2	4.50e-04	16	37	2	PF00503
Domain	GproteinA_insert	GNAI1 GNAT2	4.50e-04	16	37	2	IPR011025
Domain	G_alpha	GNAI1 GNAT2	4.50e-04	16	37	2	SM00275
Domain	-	GNAI1 GNAT2	4.50e-04	16	37	2	1.10.400.10
Domain	Gprotein_alpha_su	GNAI1 GNAT2	5.10e-04	17	37	2	IPR001019
Domain	Spectrin	CCDC141 SPTBN1	9.41e-04	23	37	2	PF00435
Domain	S_100	S100A7 S100A7A	1.30e-03	27	37	2	PF01023
Domain	S100_Ca-bd_sub	S100A7 S100A7A	1.40e-03	28	37	2	IPR013787
Domain	S100/CaBP-9k_CS	S100A7 S100A7A	1.40e-03	28	37	2	IPR001751
Domain	S_100	S100A7 S100A7A	1.40e-03	28	37	2	SM01394
Domain	Spectrin_repeat	CCDC141 SPTBN1	1.50e-03	29	37	2	IPR002017
Domain	-	SNX6 ACAP2	1.60e-03	30	37	2	1.20.1270.60
Domain	AH/BAR-dom	SNX6 ACAP2	1.60e-03	30	37	2	IPR027267
Domain	ZF_CCHC	SLU7 RBBP6	2.18e-03	35	37	2	PS50158
Domain	-	EIF5B GNAI1 SAMD9 GNAT2 DNAH8 ABCB1	3.21e-03	746	37	6	3.40.50.300
Domain	ZnF_C2HC	SLU7 RBBP6	5.31e-03	55	37	2	SM00343
Domain	Znf_CCHC	SLU7 RBBP6	5.31e-03	55	37	2	IPR001878
Domain	AGC-kinase_C	PRKACA PRKACB	5.50e-03	56	37	2	IPR000961
Domain	AGC_KINASE_CTER	PRKACA PRKACB	5.50e-03	56	37	2	PS51285
Domain	S_TK_X	PRKACA PRKACB	5.50e-03	56	37	2	SM00133
Domain	HEAT	SCYL2 EIF4G3	5.89e-03	58	37	2	IPR000357
Domain	P-loop_NTPase	EIF5B GNAI1 SAMD9 GNAT2 DNAH8 ABCB1	5.99e-03	848	37	6	IPR027417
Domain	EF_HAND_1	S100A7 S100A7A S100A7L2	7.59e-03	204	37	3	PS00018
Domain	HEAT_REPEAT	SCYL2 EIF4G3	8.47e-03	70	37	2	PS50077
Domain	EF_HAND_2	S100A7 S100A7A S100A7L2	1.06e-02	231	37	3	PS50222
Domain	EF_hand_dom	S100A7 S100A7A S100A7L2	1.08e-02	232	37	3	IPR002048
Pathway	KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY	GNAI1 PRKACA PRKACB	4.19e-06	17	27	3	M47544
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY	GNAI1 PRKACA PRKACB	1.58e-05	26	27	3	M47553
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY	GNAI1 PRKACA PRKACB	1.78e-05	27	27	3	M47519
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS	PRKACA PRKACB	3.52e-05	5	27	2	M26988
Pathway	REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS	S100A7 S100A7A	5.27e-05	6	27	2	M27622
Pathway	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	PRKACA PRKACB	5.27e-05	6	27	2	MM14628
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	GNAI1 PRKACA PRKACB	5.47e-05	39	27	3	MM14496
Pathway	WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION	GNAI1 PRKACA PRKACB	6.36e-05	41	27	3	M39655
Pathway	REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION	GNAI1 PRKACA PRKACB	7.35e-05	43	27	3	M29837
Pathway	KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME	PRKACA PRKACB	7.38e-05	7	27	2	M47896
Pathway	REACTOME_HDL_ASSEMBLY	PRKACA PRKACB	7.38e-05	7	27	2	MM15560
Pathway	REACTOME_GPER1_SIGNALING	GNAI1 PRKACA PRKACB	8.43e-05	45	27	3	M45008
Pathway	REACTOME_HDL_ASSEMBLY	PRKACA PRKACB	9.82e-05	8	27	2	M27840
Pathway	REACTOME_ROBO_RECEPTORS_BIND_AKAP5	PRKACA PRKACB	1.26e-04	9	27	2	M27877
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	GNAI1 PRKACA PRKACB	1.46e-04	54	27	3	M26911
Pathway	KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY	PRKACA PRKACB	1.57e-04	10	27	2	M47648
Pathway	REACTOME_REGULATION_OF_INSULIN_SECRETION	GNAI1 PRKACA PRKACB	2.09e-04	61	27	3	MM15071
Pathway	BIOCARTA_AKAPCENTROSOME_PATHWAY	PCNT PRKACB	2.30e-04	12	27	2	MM1460
Pathway	REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM	PRKACA PRKACB	2.30e-04	12	27	2	M27950
Pathway	REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE	PRKACA PRKACB	2.30e-04	12	27	2	M27363
Pathway	WP_DOPAMINE_METABOLISM	PRKACA PRKACB	2.72e-04	13	27	2	M39622
Pathway	BIOCARTA_AKAPCENTROSOME_PATHWAY	PCNT PRKACB	3.17e-04	14	27	2	M15347
Pathway	REACTOME_OPIOID_SIGNALLING	GNAI1 PRKACA PRKACB	3.28e-04	71	27	3	MM14491
Pathway	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	GNAI1 PRKACA PRKACB	3.42e-04	72	27	3	MM14631
Pathway	REACTOME_RAP1_SIGNALLING	PRKACA PRKACB	3.65e-04	15	27	2	MM15019
Pathway	KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY	PRKACA PRKACB	3.65e-04	15	27	2	M47794
Pathway	REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS	PRKACA PRKACB	3.65e-04	15	27	2	MM15103
Pathway	KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY	PRKACA PRKACB	3.65e-04	15	27	2	M47504
Pathway	KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY	PRKACA PRKACB	4.17e-04	16	27	2	M47551
Pathway	KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY	PRKACA PRKACB	4.17e-04	16	27	2	M47645
Pathway	REACTOME_DARPP_32_EVENTS	PRKACA PRKACB	4.17e-04	16	27	2	MM14699
Pathway	KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY	PRKACA PRKACB	4.17e-04	16	27	2	M47650
Pathway	REACTOME_RAP1_SIGNALLING	PRKACA PRKACB	4.17e-04	16	27	2	M923
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	PRKACA PRKACB	4.17e-04	16	27	2	MM14492
Pathway	REACTOME_REGULATION_OF_INSULIN_SECRETION	GNAI1 PRKACA PRKACB	4.33e-04	78	27	3	M1921
Pathway	REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING	PRKACA PRKACB	4.72e-04	17	27	2	M26995
Pathway	REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY	PRKACA PRKACB	4.72e-04	17	27	2	MM15561
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	PRKACA PRKACB	4.72e-04	17	27	2	MM15215
Pathway	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	GNAI1 PRKACA PRKACB	5.57e-04	85	27	3	M3578
Pathway	REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY	PRKACA PRKACB	5.92e-04	19	27	2	M27841
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	PRKACA PRKACB	6.57e-04	20	27	2	M759
Pathway	KEGG_GAP_JUNCTION	GNAI1 PRKACA PRKACB	6.59e-04	90	27	3	M4013
Pathway	REACTOME_OPIOID_SIGNALLING	GNAI1 PRKACA PRKACB	6.59e-04	90	27	3	M6467
Pathway	WP_G_PROTEIN_SIGNALING_PATHWAYS	GNAI1 PRKACA PRKACB	6.59e-04	90	27	3	MM15882
Pathway	WP_G_PROTEIN_SIGNALING	GNAI1 PRKACA PRKACB	6.80e-04	91	27	3	M39426
Pathway	WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS	GNAI1 PRKACA	7.25e-04	21	27	2	M39343
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	PRKACA PRKACB	7.25e-04	21	27	2	M27485
Pathway	KEGG_MELANOGENESIS	GNAI1 PRKACA PRKACB	9.21e-04	101	27	3	M7761
Pathway	REACTOME_TRIGLYCERIDE_CATABOLISM	PRKACA PRKACB	9.50e-04	24	27	2	M10064
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACA PRKACB	9.50e-04	24	27	2	M47520
Pathway	REACTOME_DARPP_32_EVENTS	PRKACA PRKACB	9.50e-04	24	27	2	M751
Pathway	PID_IL3_PATHWAY	PRKACA PRKACB	1.12e-03	26	27	2	M182
Pathway	REACTOME_CA_DEPENDENT_EVENTS	PRKACA PRKACB	1.12e-03	26	27	2	MM14495
Pathway	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	GNAI1 PRKACA PRKACB	1.12e-03	108	27	3	M17034
Pathway	KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACA PRKACB	1.20e-03	27	27	2	M47518
Pathway	REACTOME_GPER1_SIGNALING	PRKACA PRKACB	1.20e-03	27	27	2	MM15664
Pathway	KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY	PRKACA PRKACB	1.29e-03	28	27	2	M47647
Pathway	WP_CANNABINOID_RECEPTOR_SIGNALING	PRKACA PRKACB	1.39e-03	29	27	2	M39676
Pathway	WP_LIPID_METABOLISM_PATHWAY	PRKACA PRKACB	1.39e-03	29	27	2	M39762
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACA PRKACB	1.39e-03	29	27	2	M47515
Pathway	KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY	PRKACA PRKACB	1.39e-03	29	27	2	M47627
Pathway	WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS	PRKACA PRKACB	1.49e-03	30	27	2	M42578
Pathway	REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS	PRKACA PRKACB	1.59e-03	31	27	2	MM15094
Pathway	KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACA PRKACB	1.59e-03	31	27	2	M47507
Pathway	KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACA PRKACB	1.69e-03	32	27	2	M47506
Pathway	REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION	PRKACA PRKACB	1.69e-03	32	27	2	MM14983
Pathway	WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN	PRKACA PRKACB	1.80e-03	33	27	2	M48071
Pathway	WP_PURINERGIC_SIGNALING	GNAI1 GNAT2	1.80e-03	33	27	2	M39855
Pathway	PID_INTEGRIN_A4B1_PATHWAY	PRKACA PRKACB	1.80e-03	33	27	2	M277
Pathway	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	PRKACA PRKACB	1.80e-03	33	27	2	M11575
Pathway	KEGG_PRION_DISEASES	PRKACA PRKACB	2.02e-03	35	27	2	M13036
Pathway	KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY	PRKACA PRKACB	2.02e-03	35	27	2	M47969
Pathway	REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS	PRKACA PRKACB	2.02e-03	35	27	2	MM15109
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	GNAI1 PRKACA PRKACB	2.08e-03	134	27	3	M29840
Pathway	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	GNAI1 GNAT2 PRKACA PRKACB	2.09e-03	289	27	4	MM15057
Pathway	PID_GMCSF_PATHWAY	PRKACA PRKACB	2.14e-03	36	27	2	M22
Pathway	REACTOME_CA_DEPENDENT_EVENTS	PRKACA PRKACB	2.26e-03	37	27	2	M749
Pathway	REACTOME_TRIGLYCERIDE_METABOLISM	PRKACA PRKACB	2.38e-03	38	27	2	M27856
Pathway	REACTOME_RET_SIGNALING	PRKACA PRKACB	2.38e-03	38	27	2	MM15493
Pathway	REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION	GNAI1 PRKACA PRKACB	2.55e-03	144	27	3	MM14501
Pathway	REACTOME_RET_SIGNALING	PRKACA PRKACB	2.63e-03	40	27	2	M27746
Pathway	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	PRKACA PRKACB	2.63e-03	40	27	2	MM15115
Pathway	REACTOME_DAG_AND_IP3_SIGNALING	PRKACA PRKACB	2.77e-03	41	27	2	M512
Pathway	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	GNAI1 GNAT2 PRKACA PRKACB	2.83e-03	314	27	4	M600
Pathway	REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION	PRKACA PRKACB	2.90e-03	42	27	2	M791
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	GNAI1 PRKACA PRKACB	2.92e-03	151	27	3	M39329
Pathway	WP_HEDGEHOG_SIGNALING_WP4249	PRKACA PRKACB	3.04e-03	43	27	2	M39706
Pathway	REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS	PRKACA PRKACB	3.04e-03	43	27	2	M933
Pathway	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	PRKACA PRKACB	3.18e-03	44	27	2	M9011
Pathway	WP_VASOPRESSINREGULATED_WATER_REABSORPTION	PRKACA PRKACB	3.18e-03	44	27	2	M42554
Pathway	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	GNAI1 PRKACA PRKACB	3.26e-03	157	27	3	M4904
Pathway	WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS	SPTBN1 PRKACA PRKACB	3.38e-03	159	27	3	M39373
Pathway	WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS	EIF4G3 PRKACA	3.47e-03	46	27	2	M39805
Pathway	PID_HEDGEHOG_GLI_PATHWAY	GNAI1 PRKACA	3.77e-03	48	27	2	M219
Pathway	WP_TRANSLATION_FACTORS	EIF5B EIF4G3	4.09e-03	50	27	2	M39423
Pathway	KEGG_TASTE_TRANSDUCTION	PRKACA PRKACB	4.42e-03	52	27	2	M5785
Pathway	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	PRKACA PRKACB	4.42e-03	52	27	2	M920
Pathway	KEGG_VIBRIO_CHOLERAE_INFECTION	PRKACA PRKACB	4.75e-03	54	27	2	M17906
Pathway	WP_CHEMOKINE_SIGNALING_PATHWAY	GNAI1 PRKACA PRKACB	5.08e-03	184	27	3	MM15943
Pathway	KEGG_HEDGEHOG_SIGNALING_PATHWAY	PRKACA PRKACB	5.10e-03	56	27	2	M1053
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	EIF5B GNAI1 BSN EIF4G3 NCAPH DNAH8 DNAJC3 ERC1 MB SPTBN1 PIP4K2A ABCB1 PCNT PRKACA SANBR PRKACB	3.97e-13	1442	37	16	35575683
Pubmed	The mouse S100A15 ortholog parallels genomic organization, structure, gene expression, and protein-processing pattern of the human S100A7/A15 subfamily during epidermal maturation.	S100A7 S100A7A S100A7L2	1.11e-09	3	37	3	16528363
Pubmed	Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.	S100A7 S100A7A S100A7L2	1.11e-09	3	37	3	15717926
Pubmed	S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.	S100A7 S100A7A S100A7L2	1.11e-09	3	37	3	22158945
Pubmed	Comparative analysis of the physical properties of murine and human S100A7: Insight into why zinc piracy is mediated by human but not murine S100A7.	S100A7 S100A7A S100A7L2	1.11e-09	3	37	3	37769710
Pubmed	Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity.	S100A7 S100A7A S100A7L2	4.43e-09	4	37	3	18223693
Pubmed	Genomic and phylogenetic analysis of the S100A7 (Psoriasin) gene duplications within the region of the S100 gene cluster on human chromosome 1q21.	S100A7 S100A7A S100A7L2	1.11e-08	5	37	3	12664160
Pubmed	Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin.	S100A7 S100A7A S100A7L2	6.18e-08	8	37	3	23499548
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ANKRD11 EIF5B SLU7 MARVELD2 EIF4G3 SNX6 DNAJC3 SPTBN1 PCNT PRKACA PRKACB	2.58e-07	1487	37	11	33957083
Pubmed	Gene from a psoriasis susceptibility locus primes the skin for inflammation.	S100A7 S100A7A S100A7L2	3.15e-07	13	37	3	21148126
Pubmed	Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation.	S100A7 S100A7A S100A7L2	5.00e-07	15	37	3	27369778
Pubmed	Probing the S100 protein family through genomic and functional analysis.	S100A7 S100A7A S100A7L2	7.46e-07	17	37	3	15203200
Pubmed	S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature).	S100A7 S100A7A S100A7L2	8.94e-07	18	37	3	15336958
Pubmed	An update of the S100 nomenclature.	S100A7 S100A7A S100A7L2	1.06e-06	19	37	3	16938360
Pubmed	Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACB	1.10e-06	2	37	2	3023318
Pubmed	Global consequences of activation loop phosphorylation on protein kinase A.	PRKACA PRKACB	1.10e-06	2	37	2	19965870
Pubmed	Protein kinase A translocation and insulin secretion in pancreatic beta-cells: studies with adenylate cyclase toxin from Bordetella pertussis.	PRKACA PRKACB	1.10e-06	2	37	2	12180908
Pubmed	Testosterone rapidly increases Ca2+-activated K+ currents causing hyperpolarization in human coronary artery endothelial cells.	GNAI1 PRKACA	1.10e-06	2	37	2	28223151
Pubmed	Pericentrin anchors protein kinase A at the centrosome through a newly identified RII-binding domain.	PCNT PRKACA	1.10e-06	2	37	2	10753751
Pubmed	Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.	PRKACA PRKACB	1.10e-06	2	37	2	31678302
Pubmed	Systems-level identification of PKA-dependent signaling in epithelial cells.	PRKACA PRKACB	1.10e-06	2	37	2	28973931
Pubmed	Investigation of -PRKACA/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.	PRKACA PRKACB	1.10e-06	2	37	2	36152045
Pubmed	PRKACA/PRKACB Fusions in Pancreatobiliary Intraductal Oncocytic Papillary Neoplasms Including Those With Atypical Morphology: An Analysis of 22 Cases Expanding Morphologic Spectrum.	PRKACA PRKACB	1.10e-06	2	37	2	38841868
Pubmed	Gene Rearrangement and Expression of PRKACA and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms.	PRKACA PRKACB	1.10e-06	2	37	2	37871652
Pubmed	Molecular and behavioral effects of a null mutation in all PKA C beta isoforms.	PRKACA PRKACB	1.10e-06	2	37	2	12139926
Pubmed	Characterization of genomic clones coding for the C alpha and C beta subunits of mouse cAMP-dependent protein kinase.	PRKACA PRKACB	1.10e-06	2	37	2	2833513
Pubmed	Protein kinase A acts at the basal body of the primary cilium to prevent Gli2 activation and ventralization of the mouse neural tube.	PCNT PRKACA PRKACB	1.45e-06	21	37	3	22007132
Pubmed	BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms.	S100A7 S100A7A S100A7L2	1.68e-06	22	37	3	17276340
Pubmed	Molecular cloning of a tissue-specific protein kinase (C gamma) from human testis--representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACB	3.30e-06	3	37	2	2342480
Pubmed	Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein.	PRKACA PRKACB	3.30e-06	3	37	2	12842892
Pubmed	Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing.	PRKACA PRKACB	3.30e-06	3	37	2	17594903
Pubmed	A genetic test of the effects of mutations in PKA on mossy fiber LTP and its relation to spatial and contextual learning.	PRKACA PRKACB	3.30e-06	3	37	2	8548807
Pubmed	Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit.	PRKACA PRKACB	3.30e-06	3	37	2	18380891
Pubmed	The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.	PRKACA PRKACB	3.30e-06	3	37	2	19383776
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	EIF5B SLU7 GNAI1 SAMD9 LSM14B NCAPH RBBP6 ERC1 SPTBN1	5.10e-06	1257	37	9	36526897
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ARHGAP6 BSN EIF4G3 CCDC141 RBBP6 PCNT	5.80e-06	430	37	6	35044719
Pubmed	Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family.	S100A7 S100A7A	6.60e-06	4	37	2	12923069
Pubmed	Acidosis Mediates the Switching of Gs-PKA and Gi-PKCε Dependence in Prolonged Hyperalgesia Induced by Inflammation.	GNAI1 PRKACA	6.60e-06	4	37	2	25933021
Pubmed	Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-kappaB promotes Schwann cell differentiation into a myelinating phenotype.	PRKACA PRKACB	6.60e-06	4	37	2	18385332
Pubmed	Cloning of a mouse protein kinase A catalytic subunit pseudogene and chromosomal mapping of C subunit isoforms.	PRKACA PRKACB	6.60e-06	4	37	2	7873880
Pubmed	Glucose-dependent regulation of AMP-activated protein kinase in MIN6 beta cells is not affected by the protein kinase A pathway.	PRKACA PRKACB	6.60e-06	4	37	2	23116618
Pubmed	Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation.	PRKACA PRKACB	6.60e-06	4	37	2	15111495
Pubmed	GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor.	PRKACA PRKACB	6.60e-06	4	37	2	31112131
Pubmed	Phosphorylation of a threonine unique to the short C-terminal isoform of betaII-spectrin links regulation of alpha-beta spectrin interaction to neuritogenesis.	SPTBN1 PRKACA	6.60e-06	4	37	2	17088250
Pubmed	Agonist dose-dependent phosphorylation by protein kinase A and G protein-coupled receptor kinase regulates beta2 adrenoceptor coupling to G(i) proteins in cardiomyocytes.	GNAI1 PRKACA	6.60e-06	4	37	2	19706594
Pubmed	Discrete control of TRPV4 channel function in the distal nephron by protein kinases A and C.	PRKACA PRKACB	6.60e-06	4	37	2	23709216
Pubmed	Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.	S100A7 S100A7A	6.60e-06	4	37	2	18606705
Pubmed	Germline and Mosaic Variants in PRKACA and PRKACB Cause a Multiple Congenital Malformation Syndrome.	PRKACA PRKACB	6.60e-06	4	37	2	33058759
Pubmed	Differential role of PKA catalytic subunits in mediating phenotypes caused by knockout of the Carney complex gene Prkar1a.	PRKACA PRKACB	6.60e-06	4	37	2	21852354
Pubmed	Developmentally acquired PKA localisation in mouse oocytes and embryos.	PRKACA PRKACB	1.10e-05	5	37	2	18367160
Pubmed	HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.	PRKACA PRKACB	1.10e-05	5	37	2	12972513
Pubmed	Involvement of protein kinase A in patterning of the mouse somatosensory cortex.	PRKACA PRKACB	1.10e-05	5	37	2	16707791
Pubmed	Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.	PRKACA PRKACB	1.10e-05	5	37	2	19483721
Pubmed	Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin.	S100A7 S100A7A	1.10e-05	5	37	2	1940442
Pubmed	PKACs attenuate innate antiviral response by phosphorylating VISA and priming it for MARCH5-mediated degradation.	PRKACA PRKACB	1.10e-05	5	37	2	28934360
Pubmed	HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.	PRKACA PRKACB	1.10e-05	5	37	2	21745501
Pubmed	S100A15, an antimicrobial protein of the skin: regulation by E. coli through Toll-like receptor 4.	S100A7 S100A7A	1.10e-05	5	37	2	17625598
Pubmed	Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.	PRKACA PRKACB	1.10e-05	5	37	2	9540970
Pubmed	PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity.	PRKACA PRKACB	1.10e-05	5	37	2	19711044
Pubmed	Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls.	PRKACA PRKACB	1.10e-05	5	37	2	19573263
Pubmed	Phosphorylation of the neurogenic transcription factor SOX11 on serine 133 modulates neuronal morphogenesis.	PRKACA PRKACB	1.65e-05	6	37	2	30385877
Pubmed	A gut-derived hormone regulates cholesterol metabolism.	GNAI1 PRKACA	1.65e-05	6	37	2	38503280
Pubmed	Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy.	PRKACA PRKACB	1.65e-05	6	37	2	17557924
Pubmed	Architectural DNA-binding properties of the spermatidal transition proteins 1 and 2.	PRKACA PRKACB	1.65e-05	6	37	2	9837753
Pubmed	Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation.	PRKACA PRKACB	1.65e-05	6	37	2	19197368
Pubmed	Epithelial genes in chronic rhinosinusitis with and without nasal polyps.	S100A7 SPINK5	1.65e-05	6	37	2	18588753
Pubmed	Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.	LRRCC1 PCNT PRKACA PRKACB	1.77e-05	146	37	4	21399614
Pubmed	Evolution of the mammalian G protein alpha subunit multigene family.	GNAI1 GNAT2 ABCB1	1.97e-05	49	37	3	1302014
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	EIF5B EIF4G3 LSM14B SNX6 NCAPH ERC1 SPTBN1 PRKACA	2.28e-05	1149	37	8	35446349
Pubmed	Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain.	PRKACA PRKACB	2.30e-05	7	37	2	2619996
Pubmed	Dynamic binding of PKA regulatory subunit RI alpha.	PRKACA PRKACB	2.30e-05	7	37	2	16407073
Pubmed	Phosphorylation of HIV Nef by cAMP-dependent protein kinase.	PRKACA PRKACB	2.30e-05	7	37	2	15629779
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	EIF4G3 SNX6 NCAPH ERC1 SPTBN1 PIP4K2A PCNT	2.70e-05	847	37	7	35235311
Pubmed	Control of PKA stability and signalling by the RING ligase praja2.	PRKACA PRKACB	3.07e-05	8	37	2	21423175
Pubmed	CCL3L1 prevents gp120-induced neuron death via the CREB cell signaling pathway.	PRKACA PRKACB	3.07e-05	8	37	2	19100722
Pubmed	Accumulation in fetal muscle and localization to the neuromuscular junction of cAMP-dependent protein kinase A regulatory and catalytic subunits RI alpha and C alpha.	PRKACA PRKACB	3.07e-05	8	37	2	8794865
Pubmed	Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).	PRKACA PRKACB	3.07e-05	8	37	2	12628924
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CNTLN BSN RBBP6 ERC1 PIP4K2A PCNT	3.39e-05	588	37	6	38580884
Pubmed	Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis.	GNAI1 PCNT	3.95e-05	9	37	2	38651641
Pubmed	Protein kinase A deficiency causes axially localized neural tube defects in mice.	PRKACA PRKACB	3.95e-05	9	37	2	11886853
Pubmed	Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes.	PRKACA PRKACB	3.95e-05	9	37	2	7688126
Pubmed	Ellis-van Creveld Syndrome	PRKACA PRKACB	3.95e-05	9	37	2	37903214
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	GNAT2 BSN ERC1 SPTBN1 PRKACA PRKACB	4.59e-05	621	37	6	22794259
Pubmed	HIV-1 Tat-peptide inhibits protein kinase C and protein kinase A through substrate competition.	PRKACA PRKACB	4.93e-05	10	37	2	20433920
Pubmed	The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2.	GNAI1 GNAT2	4.93e-05	10	37	2	8521505
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SCYL2 EIF5B EIF4G3 NCAPH RBBP6 ERC1 PCNT	5.02e-05	934	37	7	33916271
Pubmed	Neural crest-specific loss of Prkar1a causes perinatal lethality resulting from defects in intramembranous ossification.	PRKACA PRKACB	6.02e-05	11	37	2	20534695
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GNAI1 BSN ERC1 SPTBN1 PCNT PRKACA PRKACB	6.08e-05	963	37	7	28671696
Pubmed	PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.	PRKACA PRKACB	7.22e-05	12	37	2	10830164
Pubmed	A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells.	ANKRD11 EIF5B SLU7 RBBP6 PCNT	7.86e-05	419	37	5	28700943
Pubmed	Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.	PRKACA PRKACB	8.53e-05	13	37	2	18836454
Pubmed	Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein.	GNAI1 GNAT2	8.53e-05	13	37	2	8208289
Pubmed	Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children.	PRKACA PRKACB	8.53e-05	13	37	2	19895210
Pubmed	Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins.	GNAI1 GNAT2	8.53e-05	13	37	2	16892066
Pubmed	The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells.	PRKACA PRKACB	8.53e-05	13	37	2	20402410
Pubmed	Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection.	PRKACA PRKACB	8.53e-05	13	37	2	20392842
Pubmed	Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A.	PCNT PRKACA PRKACB	9.26e-05	82	37	3	30274258
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SCYL2 EIF5B S100A7 SLU7 LSM14B PRKACA PRKACB	9.72e-05	1038	37	7	26673895
Pubmed	Calcium channels link the muscle-derived synapse organizer laminin β2 to Bassoon and CAST/Erc2 to organize presynaptic active zones.	BSN ERC1	9.94e-05	14	37	2	21228161
Pubmed	O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.	BSN SPTBN1	9.94e-05	14	37	2	16452088
Interaction	S100A7L2 interactions	S100A7 S100A7A S100A7L2	6.78e-07	10	37	3	int:S100A7L2
Interaction	NDC80 interactions	LRRCC1 CNTLN SNX6 DNAJC3 ERC1 PCNT	2.04e-05	312	37	6	int:NDC80
Interaction	PDE4DIP interactions	ANKRD11 S100A7 SNX6 PRKACA PRKACB	2.35e-05	189	37	5	int:PDE4DIP
Interaction	MAPRE1 interactions	EIF5B ERC1 SPTBN1 ABCB1 PCNT PRKACA PRKACB	3.57e-05	514	37	7	int:MAPRE1
Interaction	AKAP9 interactions	SCYL2 SLU7 PCNT PRKACA PRKACB	4.96e-05	221	37	5	int:AKAP9
Interaction	DYNLL2 interactions	BSN PCNT PRKACA IHO1 PRKACB	1.13e-04	263	37	5	int:DYNLL2
Interaction	ZNF674 interactions	S100A7 S100A7A	1.17e-04	9	37	2	int:ZNF674
Cytoband	Ensembl 112 genes in cytogenetic band chr7q21	GNAI1 SAMD9 ABCB1	4.04e-04	178	37	3	chr7q21
Cytoband	2q11.2	EIF5B NCAPH	1.56e-03	72	37	2	2q11.2
Cytoband	3p21.31	BSN IHO1	2.98e-03	100	37	2	3p21.31
Cytoband	1q21.3	S100A7A S100A7L2	4.05e-03	117	37	2	1q21.3
Cytoband	Ensembl 112 genes in cytogenetic band chr1q21	S100A7 S100A7A S100A7L2	4.21e-03	404	37	3	chr1q21
Cytoband	Ensembl 112 genes in cytogenetic band chr2q11	EIF5B NCAPH	6.81e-03	153	37	2	chr2q11
GeneFamily	S100 calcium binding proteins\|EF-hand domain containing	S100A7 S100A7A	1.73e-04	21	17	2	459
GeneFamily	EF-hand domain containing	S100A7 S100A7A S100A7L2	1.05e-03	219	17	3	863
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ACAP2 SPTBN1	1.57e-02	206	17	2	682
GeneFamily	Ankyrin repeat domain containing	ANKRD11 ACAP2	2.13e-02	242	17	2	403
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	ANKRD11 EIF5B SLU7 SNX6 CCDC141 PIP4K2A SANBR	7.41e-06	523	37	7	M12707
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	ANKRD11 EIF5B SLU7 SNX6 CCDC141 PIP4K2A SANBR	8.49e-06	534	37	7	MM1054
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	ANKRD11 LRRCC1 EIF5B MARVELD2 CNTLN FYB1 RBBP6 PCNT SANBR	2.86e-05	983	36	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
ToppCell	PND10-Immune-Immune_Myeloid-Granulocytic-Mast\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MARVELD2 FYB1 ABCB1 PRKACB	8.30e-06	160	36	4	6393e3d5c5c8176c93aecd89b313bd054a00d474
ToppCell	PND10-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MARVELD2 FYB1 ABCB1 PRKACB	8.30e-06	160	36	4	2065938e944eb99478fd8132c2c03adeaee6d447
ToppCell	TCGA-Head_and_Esophagus\|World / Sample_Type by Project: Shred V9	S100A7 S100A7A SAMD9 SPINK5	1.10e-05	172	36	4	eb18aa179db1818f408c38e442ecfed8582d7dbc
ToppCell	Adult-Immune-natural_killer_cell-D175\|Adult / Lineage, Cell type, age group and donor	NCAPH FYB1 PIP4K2A ABCB1	1.32e-05	180	36	4	fc59e28f39e7d4fb1bcc7205202cf39224b70d7b
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo\|lymph-node_spleen / Manually curated celltypes from each tissue	NCAPH PIP4K2A ABCB1 PRKACB	1.63e-05	190	36	4	4225bfa10a6fb909a3ba8ac26f3541c390b46737
ToppCell	NS-moderate-d_07-13-Lymphoid-CTL\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FYB1 PIP4K2A ABCB1 PRKACB	1.70e-05	192	36	4	ab2c3d829f5cbf4eb386babcfdf851222a2a88e8
ToppCell	COVID-19-lung-CD8+_T_cells\|lung / Disease (COVID-19 only), tissue and cell type	FYB1 PIP4K2A ABCB1 PRKACB	1.74e-05	193	36	4	780e23e2705fc5c1b70e37568b79731ced5038bd
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANKRD11 EIF4G3 ERC1 FMN1	1.74e-05	193	36	4	779276e775cb2492e8dd36436295a536084a6415
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SNX6 CCDC141 FYB1 FMN1	1.77e-05	194	36	4	1dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	ANKRD11 EIF5B SAMD9 RBBP6	1.96e-05	199	36	4	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	COVID_non-vent-Lymphocytic-ILC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SAMD9 PIP4K2A ABCB1 PRKACB	1.96e-05	199	36	4	df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	ANKRD11 EIF5B FYB1 DNAJC3	1.96e-05	199	36	4	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-gdT\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CCDC141 PIP4K2A ABCB1 PRKACB	1.96e-05	199	36	4	74d53ad732dd29ad84d81f9c72f586f6c7bc5c57
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	ANKRD11 EIF5B RBBP6 DNAJC3	1.96e-05	199	36	4	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	COVID_non-vent-Lymphocytic-ILC-NK_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SAMD9 PIP4K2A ABCB1 PRKACB	1.96e-05	199	36	4	ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T\|COVID-19_Mild / Disease, condition lineage and cell class	SAMD9 CCDC141 SPTBN1 PIP4K2A	1.96e-05	199	36	4	f307d4887b28cf60a591439e278fd668409cb104
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	ANKRD11 EIF5B SAMD9 RBBP6	1.96e-05	199	36	4	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 PIP4K2A ABCB1 PRKACB	2.00e-05	200	36	4	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-2\|TCGA-Brain / Sample_Type by Project: Shred V9	S100A7 SLU7 S100A7A	1.91e-04	139	36	3	6f6c64eaa1ce84e0aa9a0caa9c4d9bf7afe626df
ToppCell	Leuk-UTI-Lymphocyte-T_NK-MAIT\|Leuk-UTI / Disease, Lineage and Cell Type	ARHGAP6 MARVELD2 ABCB1	2.54e-04	153	36	3	ac3a1d1b5bf6009df818fd757dad7382d95c60dc
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SNX6 FYB1 PIP4K2A	2.58e-04	154	36	3	79ebda35dd1719e157738d7c13e5b8ccc3991f03
ToppCell	facs-Lung-nan-3m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FYB1 FMN1 PIP4K2A	2.68e-04	156	36	3	69e6e8810d1738a66c9821910f41498931cf30cc
ToppCell	facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FYB1 FMN1 PIP4K2A	2.68e-04	156	36	3	3f0b9e35d4da85c90759b930052e5b9c3cde9b15
ToppCell	COVID-19-Myeloid-Dendritic_cells\|COVID-19 / group, cell type (main and fine annotations)	FYB1 FMN1 PIP4K2A	2.68e-04	156	36	3	a07a9096799e4ba663841c70035b4b32c1fda4f9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP6 SAMD9 ABCB1	3.16e-04	165	36	3	7978eefcfc40175e933f7a8b64a5dd1c661dd1ac
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|356C / Donor, Lineage, Cell class and subclass (all cells)	CCDC141 FMN1 SANBR	3.22e-04	166	36	3	c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d
ToppCell	normal_Lung-Myeloid_cells-CD163+CD14+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	NCAPH FYB1 ABCB1	3.22e-04	166	36	3	07b498eb341abec02a3ccaae320bdbb5cd6883c5
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CCDC141 SPTBN1 ABCB1	3.28e-04	167	36	3	94642b3dae035fedb6e8b9745f440096a4539f3c
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CCDC141 SPTBN1 ABCB1	3.28e-04	167	36	3	42b299273a6c72a625b204d55f4f3c4eebd6d185
ToppCell	BAL-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CCDC141 SPTBN1 ABCB1	3.28e-04	167	36	3	ecf5bc634e1e01efd783617eb81d1704e903ea21
ToppCell	AT1-AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	MARVELD2 CCDC141 SPTBN1	3.39e-04	169	36	3	815474855a70498a74e52f6583113c63b7267a0c
ToppCell	NS-moderate-d_0-4-Epithelial-Squamous\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	S100A7 SAMD9 SPINK5	3.39e-04	169	36	3	4a5d023ffcf83312d29b1d215eb6b744ef1a0777
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FYB1 PIP4K2A ABCB1	3.39e-04	169	36	3	f06118754fa62c580b4bcbecff6f9e5fdc2106a0
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK-NK\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SAMD9 FYB1 ABCB1	3.45e-04	170	36	3	9a47d03f7eea6299a836a0eb1e7c1252c03f76df
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK-NK-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SAMD9 FYB1 ABCB1	3.45e-04	170	36	3	4252c0a335762508bd1f8f71c6e78a657d7df125
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	CCDC141 FYB1 FMN1	3.45e-04	170	36	3	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SAMD9 FYB1 ABCB1	3.45e-04	170	36	3	0aa11d8cb44403b6769860dac2d3b05da6fff79d
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CCDC141 FMN1 SANBR	3.57e-04	172	36	3	a9e13aa36087170dadca421ba9de588e5a1cf715
ToppCell	T_cells-CD56_bright_CD16-_NK_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	GNAI1 CCDC141 ABCB1	3.57e-04	172	36	3	980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SNX6 FYB1 PIP4K2A	3.57e-04	172	36	3	c96bd3407911df3e3e6d7a3dba786b11814b9598
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-secretory_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP6 CCDC141 NCAPH	3.63e-04	173	36	3	766e712e4db440468a32971459c1d3354add611f
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP6 CCDC141 NCAPH	3.63e-04	173	36	3	40ef91afb366e87b5ba2951d2578ebfe04d042c0
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP6 SAMD9 ABCB1	3.70e-04	174	36	3	912a9e892b29d945666fc37c986009c97c668ac8
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP6 SAMD9 ABCB1	3.70e-04	174	36	3	e0de0a14319be1a115e5be05d6f9b562e7b32c4a
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNTLN NCAPH DNAH8	3.70e-04	174	36	3	9d5dcd46cf346c381dea68ada6665f7fb68114a3
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNTLN NCAPH DNAH8	3.70e-04	174	36	3	53cec5c666c45278a71c21dd9c62a052a97e0fdf
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CCDC141 FMN1 SANBR	3.76e-04	175	36	3	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	3'-Adult-Distal_Rectal-Epithelial-Tuft-related-Microfold_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FYB1 ABCB1 SPINK5	3.76e-04	175	36	3	8a37b2811f39bb9baa537e8755a29d559eb8185a
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAJC3 ABCB1 IHO1	3.82e-04	176	36	3	acb9e29773030f6452a069f8f7e53eab68ab7bd3
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAJC3 ABCB1 IHO1	3.82e-04	176	36	3	606704098bfdf8bfef740a3544a372fae1e75969
ToppCell	3'-Adult-Distal_Rectal-Epithelial-Tuft-related\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FYB1 ABCB1 SPINK5	3.95e-04	178	36	3	a95bb77a2c2ce7c38989e6f971812f7ee9f5bd4b
ToppCell	Control-T/NK-NK\|Control / Disease group,lineage and cell class （2021.01.30）	CCDC141 SPTBN1 ABCB1	3.95e-04	178	36	3	079fd19bdeed86bf985c4083af432432d66ad546
ToppCell	Children_(3_yrs)\|World / Lineage, Cell type, age group and donor	CCDC141 FYB1 FMN1	3.95e-04	178	36	3	df2ecd3214590b914f2762db57efe780ba038db3
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	FYB1 SPTBN1 PRKACB	3.95e-04	178	36	3	31c847d7f7aa0f6d820afbb45d507992f5e9dc2f
ToppCell	facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BSN FMN1 ABCB1	4.01e-04	179	36	3	5297f7459b40ca780a1983fecc1bb9c035c7677e
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	S100A7 S100A7A SPINK5	4.01e-04	179	36	3	2b5f8e109a67c7fc3ec2b83e8f1854160c99283a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP6 GNAI1 FMN1	4.08e-04	180	36	3	a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP6 GNAI1 FMN1	4.08e-04	180	36	3	eee71184ebed2694d3e60f579a44b3cf7dd2cd35
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP6 ERC1 ABCB1	4.15e-04	181	36	3	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	COVID-19-T_cells-Tregs\|COVID-19 / group, cell type (main and fine annotations)	CCDC141 FYB1 DNAH8	4.15e-04	181	36	3	534659cf754326c6a73c0daa30e9d610612a0292
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PIP4K2A ABCB1 PRKACB	4.21e-04	182	36	3	9d727ab84da8de33f1021b492c90d8b4c2a8ea23
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FYB1 FMN1 SPTBN1	4.21e-04	182	36	3	9ba85f621a846531a2a7861e9df695d288c9e149
ToppCell	PSB-critical-LOC-Epithelial-Squamous\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	S100A7 SAMD9 SPINK5	4.28e-04	183	36	3	2cf798a2371c61322484ea16fdfae0acfa94f102
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|bone_marrow / Manually curated celltypes from each tissue	PIP4K2A ABCB1 PRKACB	4.28e-04	183	36	3	37db007cc65005bffc18a5fda7f454a57c9fb0a9
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo\|bone_marrow / Manually curated celltypes from each tissue	PIP4K2A ABCB1 PRKACB	4.28e-04	183	36	3	2fb78622adc170dd3301e251418337523de50faf
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKRD11 EIF4G3 SPTBN1	4.35e-04	184	36	3	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SNX6 FYB1 FMN1	4.42e-04	185	36	3	8207f9eff113eed429e961748c6b17d672a13b33
ToppCell	Control-T_cells-CD8+_T_cells\|Control / group, cell type (main and fine annotations)	FYB1 PIP4K2A ABCB1	4.42e-04	185	36	3	02ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic\|lymph-node_spleen / Manually curated celltypes from each tissue	CNTLN NCAPH MB	4.42e-04	185	36	3	912d8efdc37820dbb07736221a98af929e5a7c97
ToppCell	Control-T_cells-NK_cells\|Control / group, cell type (main and fine annotations)	FYB1 PIP4K2A ABCB1	4.42e-04	185	36	3	755c0998c729f462399f1d5e88adf4bfae31be30
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP6 GNAI1 FMN1	4.42e-04	185	36	3	03f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP6 GNAI1 FMN1	4.49e-04	186	36	3	1850583d23903d08226aeb0edb3e07b0994330e4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP6 GNAI1 FMN1	4.49e-04	186	36	3	4dafc215c42e7949f932a3627359c107943b5d6b
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	LRRCC1 NCAPH ERC1	4.49e-04	186	36	3	74eb69a52090f9e2426a47e03a1c478ee0cfec18
ToppCell	TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6\|TCGA-Skin / Sample_Type by Project: Shred V9	S100A7 S100A7A SPINK5	4.56e-04	187	36	3	2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f
ToppCell	ILEUM-inflamed-(1)_CD8_Trm\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FYB1 PIP4K2A ABCB1	4.56e-04	187	36	3	a77d7ae44f47410bd92fb3aa0f44dce891752b63
ToppCell	Monocytes-M2-like_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	ARHGAP6 SNX6 CCDC141	4.56e-04	187	36	3	59e31c51183ed4c9a3d0792c8005ea3a12b28dfa
ToppCell	droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNTLN DNAH8 SPTBN1	4.56e-04	187	36	3	14c239af77116d28d511dea754b6150d20488080
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	LRRCC1 NCAPH ERC1	4.56e-04	187	36	3	1eed2c1a05e80a7c8f639437c117afe0c18dfb0c
ToppCell	VE-Treg\|VE / Condition, Cell_class and T cell subcluster	SAMD9 CCDC141 DNAH8	4.63e-04	188	36	3	ef048517dfe2fc995d13eb1f08106a487354a4cc
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PIP4K2A ABCB1 PRKACB	4.63e-04	188	36	3	f8e6247bedc0ba494c5bb551539cb8ba5a97f557
ToppCell	VE-Treg-CD4_Treg\|VE / Condition, Cell_class and T cell subcluster	SAMD9 CCDC141 DNAH8	4.63e-04	188	36	3	fa88ceb336e30de3585e62608527a0d44df74190
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FYB1 PIP4K2A ABCB1	4.63e-04	188	36	3	6686dbba990066568aa7573e70a7db8b4758f457
ToppCell	COPD-Lymphoid-NK\|COPD / Disease state, Lineage and Cell class	PIP4K2A ABCB1 PRKACB	4.63e-04	188	36	3	c9a227c8e71b69929d43e9afb8306a95c8163778
ToppCell	Control-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	ARHGAP6 MARVELD2 SPTBN1	4.63e-04	188	36	3	88b3415e33db81726dd29c1f50c886e057af50a0
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PIP4K2A ABCB1 PRKACB	4.63e-04	188	36	3	8155bc5476fc333bedcc78c5ddcc8e4912536caa
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	FYB1 SPTBN1 PRKACB	4.70e-04	189	36	3	e9df7ecd36bee1fedce23bb188c68a94fa60462c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC141 FYB1 PIP4K2A	4.70e-04	189	36	3	b87d586a9570fa54f3e0c6bd4731c5badcaedae6
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC141 FYB1 PIP4K2A	4.70e-04	189	36	3	823d6debd09e440ddf36c54af24a5f20e222a21e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC141 FYB1 PIP4K2A	4.70e-04	189	36	3	47c2b419b081d5bf75da5e3d9a0e05a70362dfe7
ToppCell	3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SAMD9 FYB1 ABCB1	4.70e-04	189	36	3	637f26503e4bd7b4e5642ec1a722ffabcda4fac7
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	PIP4K2A ABCB1 PRKACB	4.70e-04	189	36	3	e8ff2c4fd2481bfbc99a5a6f02e0db8c995b3a23
ToppCell	3'-Airway_Nasal-Immune_Lymphocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SAMD9 FYB1 ABCB1	4.70e-04	189	36	3	2424e4dc9e8c7f5b3b31272405c6c1d4c8af6d9e
ToppCell	COVID-19-T_cells-CD8+_T_cells\|COVID-19 / group, cell type (main and fine annotations)	FYB1 PIP4K2A PRKACB	4.70e-04	189	36	3	2c018d6120f65f0b2704b483bc9da1c0984872e3
ToppCell	T_cells-GZMK+_CD8+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CCDC141 FYB1 PIP4K2A	4.70e-04	189	36	3	e2ca075aedf7c370ab4ede6272254ffd06cbcdec
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CCDC141 FYB1 FMN1	4.70e-04	189	36	3	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FYB1 PIP4K2A ABCB1	4.70e-04	189	36	3	c604da558c9f4055fb36218452463539f2a73223
ToppCell	COVID-19-T_cells-NK_cells\|COVID-19 / group, cell type (main and fine annotations)	PIP4K2A ABCB1 PRKACB	4.70e-04	189	36	3	b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	GNAI1 EIF4G3 FMN1	4.78e-04	190	36	3	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CNTLN PCNT SANBR	4.78e-04	190	36	3	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
Drug	NA-382	ABCB1 PRKACA PRKACB	1.77e-06	15	37	3	CID000132534
Drug	8-azidoadenosine	ABCB1 PRKACA PRKACB	3.76e-06	19	37	3	CID000160751
Drug	H 85	ABCB1 PRKACA PRKACB	1.00e-05	26	37	3	CID006439306
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A	ANKRD11 EIF4G3 NCAPH ACAP2 RBBP6	1.07e-05	181	37	5	1791_DN
Drug	AC1L1CLB	SPTBN1 ABCB1 PRKACA PRKACB	1.49e-05	92	37	4	CID000001951
Drug	AC1O5WLA	ABCB1 PRKACA PRKACB	1.56e-05	30	37	3	CID006442113
Drug	HSR-903	SPTBN1 ABCB1	3.84e-05	6	37	2	CID000477670
Drug	Co K	MB ABCB1	3.84e-05	6	37	2	CID006852202
Disease	McCune Albright syndrome (implicated_via_orthology)	GNAI1 GNAT2	4.03e-05	8	36	2	DOID:1858 (implicated_via_orthology)
Disease	brain ischemia (biomarker_via_orthology)	ABCB1 PRKACA PRKACB	2.64e-04	102	36	3	DOID:2316 (biomarker_via_orthology)
Disease	Intrahepatic Cholangiocarcinoma	PRKACA PRKACB	3.93e-04	24	36	2	C0345905
Disease	Extrahepatic Cholangiocarcinoma	PRKACA PRKACB	3.93e-04	24	36	2	C3805278
Disease	Cholangiocarcinoma	PRKACA PRKACB	4.62e-04	26	36	2	C0206698
Disease	urate measurement, bone density	SCYL2 ANKRD11 DNAH8 ERC1 PRKACB	8.80e-04	619	36	5	EFO_0003923, EFO_0004531

Protein segments in the cluster

Peptide	Gene	Start	Entry
EFDKCFKEKKDTKEK	ANKRD11	1051	Q6UB99
KEFSDLEKKFKDKSQ	CNTLN	206	Q9NXG0
NFVKEDLRKFKDAKK	ACAP2	111	Q15057
DLRKFKDAKKQFEKV	ACAP2	116	Q15057
FQNEEEKKKAEKKFI	DNAJC3	426	Q13217
EIDNYKKDLKDLKEK	ERC1	646	Q8IUD2
DKLEEFFQKAKKEHK	FMN1	1301	Q68DA7
LFLNKKDLFEEKIKK	GNAI1	266	P63096
FFKLNNKSEKDKKEK	ABCB1	16	P08183
VKEFLAKAKEDFLKK	PRKACA	16	P17612
LEQFEEKKKRAKDKC	IHO1	116	Q8IYA8
FFQAEEEEKKKKEGK	SPINK5	406	Q9NQ38
ELDKEFKKKLNFKDD	LSM14B	266	Q9BX40
RDLAFAEDKKKEKQF	BSN	1276	Q9UPA5
DKEDEFKKECKEVFA	DNAH8	826	Q96JB1
DLKKLKKQEKEEKDF	FYB1	681	O15117
LEDLEFKFKESEKEK	PCNT	431	O95613
FKFKESEKEKQLELE	PCNT	436	O95613
EEKKKSKLDEFTNDF	RBBP6	651	Q7Z6E9
KLDSLGKEKNKDKEF	ARHGAP6	261	O43182
VKEFLAKAKEDFLKK	PRKACB	16	P22694
INELKDSFKDIKKKF	CCDC141	906	Q6ZP82
EEFKKKKNDPTFLEK	MARVELD2	511	Q8N4S9
KKDKNEDKKIDFSEF	S100A7A	61	Q86SG5
KKDDNKDKKVNYSEF	S100A7L2	61	Q5SY68
EKDKADDDVFEKKQK	EIF4G3	846	O43432
NKKVFLEKLKKDVEF	PIP4K2A	251	P48426
EKDKNKFLEFKASKE	SAMD9	666	Q5K651
KEKKKQDFDEDDILK	EIF5B	46	O60841
LFLNKKDLFEEKIKK	GNAT2	266	P19087
FDKKLIDKYQKFEKD	SCYL2	66	Q6P3W7
DDLKDKKDKFKSKLF	SANBR	286	Q6NSI8
EKDKEKDKEKRFSLF	SPTBN1	2346	Q01082
NKKKSTKKDFEIDFE	NCAPH	461	Q15003
ADVFEKKDKNEDKKI	S100A7	56	P31151
KKDKNEDKKIDFSEF	S100A7	61	P31151
SFKVKKEDFKEQQKE	SLU7	356	O95391
RGKNKKEKLEDFFKN	SNX6	176	Q9UNH7
LEKFDKFKHLKSEDE	MB	41	P02144
EKFENKEKKLKAERD	LRRCC1	926	Q9C099